相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1-mediated DNA methylation mechanism
Rongrong Zhao et al.
CANCER MEDICINE (2020)
Chrysin Induced Cell Apoptosis and Inhibited Invasion Through Regulation of TET1 Expression in Gastric Cancer Cells
Xiaowei Zhong et al.
ONCOTARGETS AND THERAPY (2020)
The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells
Machiko Kojima et al.
ONCOLOGY LETTERS (2020)
EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis
Yu Zhao et al.
EMBO JOURNAL (2019)
Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor
Gerardo A. Vitiello et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
EZH2 promotes gastric cancer cells proliferation by repressing p21 expression
Jiewei Xu et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype
Ielizaveta Gorodetska et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity
Jodie Hay et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible Mechanisms
Scott R. Goldsmith et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
SMYD2 promotes cervical cancer growth by stimulating cell proliferation
Jun-Jie Sun et al.
CELL AND BIOSCIENCE (2019)
Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis
Yi Zeng et al.
CELL REPORTS (2019)
Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer
Yong Yu et al.
THERANOSTICS (2019)
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
Michael J. Thomenius et al.
PLOS ONE (2018)
Rottlerin inhibits cell growth and invasion via down-regulation of EZH2 in prostate cancer
Nana Zheng et al.
CELL CYCLE (2018)
MiR-365a-3p suppresses proliferation and invasion of Hep-2 cells through targeting ten-eleven translocation 1 (TET1)
J. Li et al.
NEOPLASMA (2018)
TET1 modulates H4K16 acetylation by controlling auto-acetylation of hMOF to affect gene regulation and DNA repair function
Jianing Zhong et al.
NUCLEIC ACIDS RESEARCH (2017)
Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease
Linda Xiaoyan Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas
Rie Ohtomo-Oda et al.
HUMAN PATHOLOGY (2016)
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2
Erik Eggert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
EZH2 mediates lidamycin-induced cellular senescence through regulating p21 expression in human colon cancer cells
Ming-Quan Sha et al.
CELL DEATH & DISEASE (2016)
EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy
Julian C. Lui et al.
NATURE COMMUNICATIONS (2016)
EZH2 regulates neuroepithelium structure and neuroblast proliferation by repressing p21
Naiara Akizu et al.
OPEN BIOLOGY (2016)
Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib
Changhoon Yoo et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
SDHC methylation in gastrointestinal stromal tumors (GIST): a case report
Milena Urbini et al.
BMC MEDICAL GENETICS (2015)
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2
Hannah Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN
Makoto Nakakido et al.
NEOPLASIA (2015)
Overexpression of SMYD2 contributes to malignant outcome in gastric cancer
S. Komatsu et al.
BRITISH JOURNAL OF CANCER (2015)
Critical roles of non-histone protein lysine methylation in human tumorigenesis
Ryuji Hamamoto et al.
NATURE REVIEWS CANCER (2015)
TET1 Exerts Its Tumor Suppressor Function by Interacting with p53-EZH2 Pathway in Gastric Cancer
Hua-Lin Fu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Gastrointestinal stromal tumour
Heikki Joensuu et al.
LANCET (2013)
EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin-Dependent Hepatocarcinogenesis
Alfred S. L. Cheng et al.
CANCER RESEARCH (2011)
Enhancer of Zeste Homolog 2 Overexpression Has a Role in the Development of Anaplastic Thyroid Carcinomas
Eleonora Borbone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Gastrointestinal stromal tumours: origin and molecular oncology
Christopher L. Corless et al.
NATURE REVIEWS CANCER (2011)
Bioinformatic Mining of Gene Expression Datasets Identifies ETV1 as a Critical Regulator of Oncogenesis in Gastrointestinal Stromal Tumors
Brian P. Rubin
CANCER CELL (2010)
Methylation of the Retinoblastoma Tumor Suppressor by SMYD2
Louis A. Saddic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma
Shuhei Komatsu et al.
CARCINOGENESIS (2009)
Protocols to detect senescence-associated beta-galactosidase (SA-beta gal) activity, a biomarker of senescent cells in culture and in vivo
Florence Debacq-Chainiaux et al.
NATURE PROTOCOLS (2009)
分享论文
